SK283299B6 - Deriváty benzo(c)chinolizínu, ich príprava a medziprodukty, ich použitie vo funkcii inhibítorov 5alfa-reduktáz a farmaceutické kompozície s ich obsahom - Google Patents

Deriváty benzo(c)chinolizínu, ich príprava a medziprodukty, ich použitie vo funkcii inhibítorov 5alfa-reduktáz a farmaceutické kompozície s ich obsahom Download PDF

Info

Publication number
SK283299B6
SK283299B6 SK1044-98A SK104498A SK283299B6 SK 283299 B6 SK283299 B6 SK 283299B6 SK 104498 A SK104498 A SK 104498A SK 283299 B6 SK283299 B6 SK 283299B6
Authority
SK
Slovakia
Prior art keywords
alkyl
benzo
phenyl
quinolizin
group
Prior art date
Application number
SK1044-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK104498A3 (en
Inventor
Antonio Guarna
Mario Serio
Original Assignee
Applied Research Systems Ars Holding N. V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N. V. filed Critical Applied Research Systems Ars Holding N. V.
Publication of SK104498A3 publication Critical patent/SK104498A3/sk
Publication of SK283299B6 publication Critical patent/SK283299B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SK1044-98A 1996-02-09 1997-02-07 Deriváty benzo(c)chinolizínu, ich príprava a medziprodukty, ich použitie vo funkcii inhibítorov 5alfa-reduktáz a farmaceutické kompozície s ich obsahom SK283299B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96FI000019A IT1286545B1 (it) 1996-02-09 1996-02-09 Derivati benzo(c) chinolizinici,loro preparazione ed uso come inibitori delle 5-alfa-riduttasi
PCT/EP1997/000552 WO1997029107A1 (en) 1996-02-09 1997-02-07 BENZO[C]QUINOLIZINE DERIVATIVES, THEIR PREPARATION AND USE AS 5α-REDUCTASES INHIBITORS

Publications (2)

Publication Number Publication Date
SK104498A3 SK104498A3 (en) 1998-12-02
SK283299B6 true SK283299B6 (sk) 2003-05-02

Family

ID=11351478

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1044-98A SK283299B6 (sk) 1996-02-09 1997-02-07 Deriváty benzo(c)chinolizínu, ich príprava a medziprodukty, ich použitie vo funkcii inhibítorov 5alfa-reduktáz a farmaceutické kompozície s ich obsahom

Country Status (26)

Country Link
US (3) US6303622B1 (cs)
EP (1) EP0880520B1 (cs)
JP (1) JP2000504680A (cs)
KR (1) KR100480448B1 (cs)
CN (1) CN1116296C (cs)
AT (1) ATE237614T1 (cs)
AU (1) AU711886C (cs)
BG (1) BG64596B1 (cs)
CZ (1) CZ298061B6 (cs)
DE (1) DE69720966T2 (cs)
DK (1) DK0880520T3 (cs)
EA (1) EA000975B1 (cs)
EE (1) EE04058B1 (cs)
ES (1) ES2192263T3 (cs)
HK (1) HK1018783A1 (cs)
HU (1) HUP9900509A3 (cs)
IL (2) IL125628A0 (cs)
IT (1) IT1286545B1 (cs)
MX (1) MX9806229A (cs)
NO (2) NO320155B1 (cs)
NZ (1) NZ331256A (cs)
PL (1) PL187618B1 (cs)
PT (1) PT880520E (cs)
SK (1) SK283299B6 (cs)
UA (1) UA67724C2 (cs)
WO (1) WO1997029107A1 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI970193A1 (it) * 1997-08-01 1999-02-01 Applied Research Systems Uso di derivati benzo(c) chinolizinici come regolatori della crescita delle piante e composizioni ad uso agricolo che contengono tali
EP0926148A1 (en) * 1997-12-23 1999-06-30 Applied Research Systems Ars Holding N.V. Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors
TR200100286T2 (tr) 1998-08-03 2001-07-23 Applied Research Systems Ars Holding N.V. (1H)-Benzo[C]kuinolizin-3-on türevlerinin sentezi için proses.
SI1928454T1 (sl) 2005-05-10 2015-01-30 Intermune, Inc. Piridonski derivati za moduliranje s stresom aktiviranega protein kinaznega sistema
EA013525B1 (ru) * 2005-05-20 2010-06-30 Алантос-Фармасьютикалз Холдинг, Инк. Гетеробициклические ингибиторы металлопротеазы и их применение
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
JP5627574B2 (ja) 2008-06-03 2014-11-19 インターミューン， インコーポレイテッド 炎症性および線維性疾患を治療するための化合物および方法
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
KR102373700B1 (ko) 2014-04-02 2022-03-11 인터뮨, 인크. 항섬유성 피리디논
CN105001216B (zh) * 2015-07-08 2017-03-01 中国科学院兰州化学物理研究所 一种喹嗪酮的制备方法
CN107089980B (zh) * 2017-05-11 2019-08-30 合肥工业大学 一种手性苯并[a]喹嗪-2-酮类化合物及其不对称催化合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1534278A (fr) * 1966-08-15 1968-07-26 Bristol Myers Co Procédé de fabrication de 1, 4-dihydroquinoléine-n-carboxylates d'alcoyle
US3455929A (en) * 1966-08-15 1969-07-15 Bristol Myers Co Esters of 1,4-dihydroquinoline-n-carboxylic acids and thione acids
US3625877A (en) * 1968-01-08 1971-12-07 Eastman Kodak Co High-modulus polycarbonate compositions
SU1027166A1 (ru) * 1981-09-11 1983-07-07 Киевский Ордена Ленина Государственный Университет Им.Т.Г.Шевченко Способ получени 1,2-полиметиленкетоцианоазагетероциклов
IE57014B1 (en) 1983-03-25 1992-03-11 Wyeth John & Brother Ltd Benzoquinolizines

Also Published As

Publication number Publication date
NO20045132L (no) 1998-07-24
AU1767297A (en) 1997-08-28
HUP9900509A3 (en) 1999-11-29
KR100480448B1 (ko) 2005-08-31
DK0880520T3 (da) 2003-08-11
US20010047098A1 (en) 2001-11-29
DE69720966D1 (de) 2003-05-22
NO320155B1 (no) 2005-11-07
NO983444D0 (no) 1998-07-24
PL187618B1 (pl) 2004-08-31
ITFI960019A0 (cs) 1996-02-09
US20010044542A1 (en) 2001-11-22
EE04058B1 (et) 2003-06-16
EP0880520B1 (en) 2003-04-16
BG102661A (en) 1999-04-30
IL125628A (en) 2006-10-31
AU711886C (en) 2002-10-17
NO983444L (no) 1998-07-24
CN1116296C (zh) 2003-07-30
IL125628A0 (en) 1999-04-11
IT1286545B1 (it) 1998-07-15
EE9800233A (et) 1998-12-15
ATE237614T1 (de) 2003-05-15
MX9806229A (es) 1998-11-30
US6552034B2 (en) 2003-04-22
US6555549B2 (en) 2003-04-29
CZ228998A3 (cs) 1998-10-14
ITFI960019A1 (it) 1997-08-09
UA67724C2 (en) 2004-07-15
HUP9900509A2 (hu) 1999-06-28
PT880520E (pt) 2003-07-31
PL328123A1 (en) 1999-01-18
ES2192263T3 (es) 2003-10-01
SK104498A3 (en) 1998-12-02
CZ298061B6 (cs) 2007-06-06
KR19990082126A (ko) 1999-11-15
EA000975B1 (ru) 2000-08-28
HK1018783A1 (en) 2000-01-07
EP0880520A1 (en) 1998-12-02
DE69720966T2 (de) 2004-05-19
JP2000504680A (ja) 2000-04-18
US6303622B1 (en) 2001-10-16
EA199800701A1 (ru) 1999-02-25
WO1997029107A1 (en) 1997-08-14
BG64596B1 (bg) 2005-08-31
NZ331256A (en) 1999-06-29
AU711886B2 (en) 1999-10-21
CN1210536A (zh) 1999-03-10

Similar Documents

Publication Publication Date Title
SK283299B6 (sk) Deriváty benzo(c)chinolizínu, ich príprava a medziprodukty, ich použitie vo funkcii inhibítorov 5alfa-reduktáz a farmaceutické kompozície s ich obsahom
CZ2001434A3 (cs) Způsob výroby chinolizin-3-onových derivátů
EP1066284B1 (en) Benzo(c)quinolizine derivatives and their use as 5 alpha-reductases inhibitors
US4734430A (en) Dipyrazoles and their use as bronchodilators
CA2245758C (en) Benzo[c]quinolizine derivatives, their preparation and use as 5.alpha.-reductases inhibitors
MXPA00006219A (en) Benzo[c]quinolizine derivatives and their use as 5 alpha-reductases inhibitors
MXPA01000869A (en) Process for the synthesis of (1h

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100207